Ergoteles LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 90 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$100,408
-69.7%
32,600
-65.3%
0.00%
-66.7%
Q3 2022$331,000
-6.0%
93,842
-31.2%
0.01%
+9.1%
Q2 2022$352,000
+23.9%
136,320
+381.7%
0.01%
+57.1%
Q2 2021$284,00028,3000.01%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 2,945,948$5,184,8681.60%
Aisling Capital Management LP 1,043,267$1,836,1500.90%
Knott David M Jr 140,921$2480.10%
XTX Topco Ltd 233,493$410,9480.07%
Pentwater Capital Management LP 5,975,000$10,516,0000.07%
Atom Investors LP 49,413$86,9670.03%
EcoR1 Capital, LLC 676,296$1,190,2810.03%
Forefront Analytics, LLC 26,619$46,8500.03%
FNY Investment Advisers, LLC 11,500$200.02%
CORNERCAP INVESTMENT COUNSEL INC 80,979$142,5230.02%
View complete list of POSEIDA THERAPEUTICS INC shareholders